Alias
科研级 Nesvacumab ( 奈伐苏单抗 ), Anti-ANGPT2 Recombinant Antibody, Research Grade Nesvacumab
Molecular Name
Nesvacumab
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
ANGPT2[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema. This drug is being developed by Regeneron Pharmaceuticals.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。